New Zealand markets open in 3 hours 5 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
8.61+0.09 (+1.06%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-11,236
-10,556
-20,804
-15,352
-12,859
-
Depreciation & amortisation
300.533
305.952
323.144
347.613
378.754
-
Stock-based compensation
-
-
3,682
1,178
1,176
1,686
Change in working capital
1,216
213.756
157.677
-761.567
-1,822
-
Accounts receivable
114.167
306.514
-252.09
-96.412
49.655
-
Other working capital
-7,832
-7,999
-16,438
-14,737
-12,239
-
Other non-cash items
1,953
2,107
3,898
1,211
2,149
-
Net cash provided by operating activities
-7,827
-7,992
-16,437
-14,705
-12,180
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-6.842
-0.581
-31.549
-59.414
-
Purchases of investments
-
-
-
-
0
-14.795
Sales/maturities of investments
-
0
3.553
1.236
0
-
Net cash used for investing activities
-4.373
-6.842
2.972
-30.313
-59.414
-
Cash flows from financing activities
Debt repayment
-234.511
-281.793
-288.076
-309.617
-367.412
-
Common stock issued
-
2,351
1,676
13,958
720.013
-
Dividends paid
0
0
0
0
0
-
Other financing activities
-173.879
-200.756
-1,103
-2,653
-236.7
-
Net cash used provided by (used for) financing activities
4,401
5,265
3,103
16,403
46.399
-
Net change in cash
-3,431
-2,735
-13,332
1,667
-12,193
-
Cash at beginning of period
5,595
6,957
20,485
18,695
31,537
-
Cash at end of period
2,164
3,865
6,957
20,485
18,695
-
Free cash flow
Operating cash flow
-7,827
-7,992
-16,437
-14,705
-12,180
-
Capital expenditure
-
-6.842
-0.581
-31.549
-59.414
-
Free cash flow
-7,832
-7,999
-16,438
-14,737
-12,239
-